Hyalex 2026

The recent 510(k) clearance of Hyalex’s Slalom™ implant is a defining moment for Hyalex, a company that was founded and initially managed by Lampros, marking its transition from deep tech development to real-world commercialization. Built on its Hydrosurf™ biomimetic materials platform, the technology aims to replicate the function of native cartilage and offer a motion-preserving alternative to traditional joint fusion—opening up a meaningful new approach in orthopedic care.